“Expression Profiling of HER2 and EGFR in Resected Specimens and Plasma Samples from Patients with Esophageal Adenocarcinoma: A Review”, AGDD, vol. 6, no. 1, pp. 14–17, Aug. 2023, doi: 10.5281/zenodo.22163696.